Tilray Brands (TLRY) 10-Q 10 Oct 24 2025 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Aug. 31, 2024	Oct. 08, 2024
Document Information [Line Items]
Entity Central Index Key	0001731348
Entity Registrant Name	Tilray Brands, Inc.
Amendment Flag	false
Current Fiscal Year End Date	--05-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2025
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2024
Document Transition Report	false
Entity File Number	001-38594
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4310622
Entity Address, Address Line One	265 Talbot Street West
Entity Address, City or Town	Leamington
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	N8H 5L4
City Area Code	844
Local Phone Number	845-7291
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	TLRY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		903,286,257

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Current assets
Cash and cash equivalents	$ 205,186	$ 228,340
Marketable securities	74,869	32,182
Accounts receivable, net	104,037	101,695
Inventory	264,295	252,087
Prepaids and other current assets	44,960	31,332
Assets held for sale	32,536	32,074
Total current assets	725,883	677,710
Capital assets	555,136	558,247
Operating lease, right-of-use assets	17,176	16,101
Intangible assets	908,768	915,469
Goodwill	2,009,714	2,008,884
Long-term investments	7,853	7,859
Convertible notes receivable	32,000	32,000
Other assets	5,337	5,395
Total assets	4,261,867	4,221,665
Liabilities, Current [Abstract]
Bank indebtedness	18,134	18,033
Accounts payable and accrued liabilities	236,146	241,957
Contingent consideration	15,000	15,000
Warrant liability	2,557	3,253
Operating and Finance Lease Liability, Current	5,640	5,091
Current portion of long-term debt	16,072	15,506
Deduct - current portion	0	330
Total current liabilities	293,549	299,170
Liabilities, Noncurrent [Abstract]
Operating and Finance Lease Liability, Noncurrent	60,657	60,422
Long-term debt	155,268	158,352
Convertible debentures payable	132,650	129,583
Deferred tax liabilities, net	136,230	130,870
Other liabilities	99	90
Total liabilities	778,453	778,487
Commitments and contingencies (refer to Note 19)
Stockholders' equity
Common stock ($0.0001 par value; 1,198,000,000 common shares authorized; 875,444,828 and 831,925,373 common shares issued and outstanding, respectively)	88	83
Preferred shares ($0.0001 par value; 10,000,000 preferred shares authorized; nil and nil preferred shares issued and outstanding, respectively)	0	0
Additional paid-in capital	6,217,533	6,146,810
Accumulated other comprehensive loss	(39,877)	(43,499)
Accumulated deficit	(2,699,653)	(2,660,488)
Total Tilray Brands, Inc. stockholders' equity	3,478,091	3,442,906
Non-controlling interests	5,323	272
Total stockholders' equity	3,483,414	3,443,178
Total liabilities and stockholders' equity	$ 4,261,867	$ 4,221,665

Consolidated Statements of Fi_2

Consolidated Statements of Financial Position (Parentheticals) - $ / shares	Aug. 31, 2024	May 31, 2024
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,198,000,000	1,198,000,000
Common stock, shares issued (in shares)	875,444,828	875,444,828
Common stock, shares outstanding (in shares)	831,925,373	831,925,373
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

Consolidated Statements of Loss

Consolidated Statements of Loss and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Net revenue	$ 200,044	$ 176,949
Cost of goods sold	140,338	132,753
Gross profit	59,706	44,196
Operating expenses:
General and administrative	44,113	40,516
Selling	11,690	6,859
Amortization	21,804	22,225
Marketing and promotion	11,566	8,535
Research and development	105	79
Change in fair value of contingent consideration	0	(11,107)
Litigation costs, net of recoveries	1,595	2,034
Restructuring costs	4,247	915
Transaction costs (income), net	1,156	8,502
Total operating expenses	96,276	78,558
Operating loss	(36,570)	(34,362)
Interest expense, net	(9,842)	(9,835)
Non-operating income (expense), net	12,646	(4,402)
Loss before income taxes	(33,766)	(48,599)
Income tax expense, net	886	7,264
Net loss	(34,652)	(55,863)
Total net income (loss) attributable to:
Stockholders of Tilray Brands, Inc.	(39,165)	(71,525)
Non-controlling interests	4,513	15,662
Other comprehensive gain (loss), net of tax
Foreign currency translation gain (loss)	4,160	3,209
Total other comprehensive gain (loss), net of tax	4,160	3,209
Comprehensive loss	(30,492)	(52,654)
Total comprehensive income (loss) attributable to:
Stockholders of Tilray Brands, Inc.	(35,543)	(68,476)
Non-controlling interests	$ 5,051	$ 15,822
Weighted average number of common shares - basic (in shares)	875,444,828	691,189,382
Weighted average number of common shares - diluted (in shares)	875,444,828	691,189,382
Net loss per share - basic (in dollars per share)	$ (0.04)	$ (0.1)
Net loss per share - diluted (in dollars per share)	$ (0.04)	$ (0.1)

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	HEXO Acquisition [Member] Common Stock and Preferred Stock [Member]	HEXO Acquisition [Member] Additional Paid-in Capital [Member]	HEXO Acquisition [Member] AOCI Attributable to Parent [Member]	HEXO Acquisition [Member] Retained Earnings [Member]	HEXO Acquisition [Member] Noncontrolling Interest [Member]	HEXO Acquisition [Member]	TLRY 27 [Member] Common Stock and Preferred Stock [Member]	TLRY 27 [Member] Additional Paid-in Capital [Member]	TLRY 27 [Member] AOCI Attributable to Parent [Member]	TLRY 27 [Member] Retained Earnings [Member]	TLRY 27 [Member] Noncontrolling Interest [Member]	TLRY 27 [Member]	Common Stock and Preferred Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at May. 31, 2023													656,655,455
Balance at May. 31, 2023													$ 66	$ 5,777,743	$ (46,610)	$ (2,415,507)	$ 14,251	$ 3,329,943
Share issuance (in shares)	39,705,962
Share issuance	$ 4	$ 65,158	$ 0	$ 0	$ 0	$ 65,162
Share issuance - acquisition settlement (in shares)													865,426
Share issuance - acquisition settlement													$ 0	1,500	0	0	0	1,500
Share issuance - Double Diamond Holdings dividend settlement (in shares)													5,004,735
Share issuance - Double Diamond Holdings dividend settlement													$ 0	8,146	0	0	0	8,146
Share issuance (in shares)													17,148,541
Share issuance - HTI convertible note													$ 2	49,998	0	0	0	50,000
Share issuance - RSUs exercised (in shares)													3,912,481
Share issuance - RSUs exercised													$ 0	0	0	0	0	0
Shares effectively repurchased for employee withholding tax													0	(4,860)	0	0	0	(4,860)
Equity component related to issuance of convertible debt, net of issuance costs							$ 0	$ 3,953	$ 0	$ 0	$ 0	$ 3,953
Stock-based compensation													0	8,257	0	0	0	8,257
Dividends declared to non-controlling interests													0	0	0	0	(7,891)	(7,891)
Comprehensive income (loss) for the period													$ 0	0	3,049	(71,525)	15,822	(52,654)
Balance (in shares) at Aug. 31, 2023													723,292,600
Balance at Aug. 31, 2023													$ 72	5,909,895	(43,561)	(2,487,032)	22,182	3,401,556
Net comprehensive (loss) income													$ 0	0	3,049	(71,525)	15,822	(52,654)
Balance (in shares) at May. 31, 2024													831,925,373
Balance at May. 31, 2024													$ 83	6,146,810	(43,499)	(2,660,488)	272	3,443,178
Share issuance - RSUs exercised (in shares)													6,823,140
Share issuance - RSUs exercised													$ 1	(1)	0	0	0	0
Shares effectively repurchased for employee withholding tax													0	(2,661)	0	0	0	(2,661)
Stock-based compensation													0	6,917	0	0	0	6,917
Comprehensive income (loss) for the period													$ 0	0	3,622	(39,165)	5,051	(30,492)
Balance (in shares) at Aug. 31, 2024													875,444,828
Balance at Aug. 31, 2024													$ 88	6,217,533	(39,877)	(2,699,653)	5,323	3,483,414
Share issuance - At-the-Market (“ATM”) program (in shares)													36,693,307
Share issuance - At-the-Market (“ATM”) program													$ 4	66,468	0	0	0	66,472
Share issuance - options exercised (in shares)													3,008
Share issuance - options exercised													$ 0	0	0	0	0	0
Net comprehensive (loss) income													$ 0	$ 0	$ 3,622	$ (39,165)	$ 5,051	$ (30,492)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Cash provided by (used in) operating activities:
Net (loss) income	$ (34,652)	$ (55,863)
Adjustments for:
Deferred income tax expense, net	382	59
Unrealized foreign exchange (gain) loss	(5,602)	(3,127)
Amortization	31,814	30,789
Accretion of convertible debt discount	3,067	5,544
Other non-cash items	729	(6,357)
Stock-based compensation	6,917	8,257
(Gain) loss on long-term investments & equity investments	(499)	47
Loss on derivative instruments	(696)	10,345
Change in fair value of contingent consideration	0	(11,107)
Change in non-cash working capital:
Accounts receivable	(2,342)	13,044
Prepaids and other current assets	(13,570)	(4,654)
Inventory	(12,383)	3,650
Accounts payable and accrued liabilities	(8,472)	(6,469)
Net cash used in operating activities	(35,307)	(15,842)
Cash provided by (used in) investing activities:
Investment in capital and intangible assets	(6,736)	(4,152)
Proceeds from disposal of capital and intangible assets	28	342
Disposal (purchase) of marketable securities, net	(42,687)	(45,436)
Business acquisitions, net of cash acquired	0	22,956
Net cash provided by (used in) investing activities	(49,395)	(26,290)
Cash provided by (used in) financing activities:
Share capital issued, net of cash issuance costs	66,472	0
Proceeds from long-term debt	0	7,621
Repayment of long-term debt	(4,791)	(6,369)
Proceeds from convertible debt	0	21,553
Repayment of convertible debt	(330)	0
Repayment of lease liabilities	(862)	0
Net increase (decrease) in bank indebtedness	101	(8,787)
Net cash provided by (used in) financing activities	60,590	14,018
Effect of foreign exchange on cash and cash equivalents	958	614
Net decrease in cash and cash equivalents	(23,154)	(27,500)
Cash and cash equivalents, beginning of period	228,340	206,632
Cash and cash equivalents, end of period	$ 205,186	$ 179,132

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 1. The accompanying unaudited condensed interim consolidated financial statements (the “Financial Statements”) reflect the accounts of the Company for the quarterly period ended August 31, 2024 not 10 May 31, 2024 not These Financial Statements have been prepared on a going concern basis, which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due, under the historical cost convention except for certain financial instruments that are measured at fair value, as detailed in the Company’s accounting policies. All amounts in the Financial Statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, and unless otherwise indicated. Certain items of the comparative figures have been changed to conform to the presentation adopted in the current period. Basis of consolidation Subsidiaries are entities controlled by the Company. Control exists when the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. The financial statements of all subsidiaries are included in the Financial Statements from the date that control commences until the date that control ceases. All intercompany balances and transactions have been eliminated on consolidation. A complete list of our subsidiaries that existed as of our most recent fiscal year end is included in the Annual Report. Convertible notes receivable Convertible notes receivable includes various investments in which the Company has the right, or potential right to convert the indenture into common stock of the investee and are classified as available-for-sale and are recorded at fair value. Unrealized gains and losses during the year, net of the related tax effect, are excluded from income and reflected in other comprehensive income (loss), and the cumulative effect is reported as a separate component of shareholders' equity until realized. We use judgement to assess convertible notes receivables for impairment at each measurement date. Convertible notes receivables are impaired when a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of loss and comprehensive loss and a new cost basis for the investment is established. We also evaluate whether there is a plan to sell the security, or it is more likely than not Earnings (loss) per share Basic earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the weighted average number of common shares outstanding during the year. Diluted earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the sum of the weighted average number of common shares and the number of dilutive potential common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options, warrants, and RSUs and the incremental shares issuable upon conversion of the convertible debentures and similar instruments. Shares of common stock outstanding under the share lending arrangement entered into in conjunction with the TLRY 27 13 In computing diluted earnings (loss) per share, common share equivalents are not three August 31, 2024 August 31, 2023 New accounting pronouncements not In August 2023, 2023 05, Business Combination - Joint Venture Formations 805 60 2023 05” 2023 05 June 1, 2026. In October 2023, 2023 06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, X June 30, 2027, not X not In December 2023, 2023 09, Income Taxes (Topic 740 2023 09 June 1, 2025. New accounting pronouncements recently adopted In November 2023, 2023 07, Segment Reporting (Topic 280 2023 07 May 31, 2025 10 On March 21, 2024, 2024 01, 718 718 10 15 3 2024 01 June 1, 2024 no

Note 2 - Inventory

Note 2 - Inventory	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	Note 2. Inventory consisted of the following: August 31, May 31, 2024 2024 Beverage alcohol inventory 58,784 $ 52,831 Plants 16,333 13,828 Dried cannabis 107,290 108,721 Cannabis derivatives 7,306 4,504 Cannabis vapes 4,858 4,132 Packaging and other inventory items 20,270 22,115 Distribution inventory 38,202 35,645 Wellness inventory 11,252 10,311 Total $ 264,295 $ 252,087

Note 3 - Capital Assets

Note 3 - Capital Assets	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 3. Capital assets consisted of the following: August 31, May 31, 2024 2024 Land $ 45,165 $ 45,577 Production facilities 375,345 369,630 Equipment 262,876 258,532 Leasehold improvements 19,463 19,377 Finance lease, right-of-use assets 43,429 43,993 Construction in progress 12,516 10,713 $ 758,794 $ 747,822 Less: accumulated amortization (203,658 ) (189,575 ) Total $ 555,136 $ 558,247 Assets held for sale consisted of the following: August 31, May 31, 2024 2024 Land $ 970 $ 954 Production facility 25,010 24,682 Equipment 6,556 6,438 $ 32,536 $ 32,074 During the fiscal year ended May 31, 2024, twelve no

Note 4 - Leases

Note 4 - Leases	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Leases Disclosure [Text Block]	Note 4. The table below presents the lease-related assets and liabilities recorded on the balance sheet. August 31, May 31, Classification on Balance Sheet 2024 2024 Assets Finance lease, right-of-use assets Capital assets $ 43,429 $ 43,993 Operating lease, right-of-use assets Operating lease, right-of-use assets 17,176 16,101 Total right-of-use asset $ 60,605 $ 60,094 Liabilities Current: Current portion of finance lease liabilities Current portion of lease liabilities $ 1,116 $ 1,092 Current portion of operating lease liabilities Current portion of lease liabilities 4,524 3,999 Non-current: Finance lease liabilities Lease liabilities 43,737 43,948 Operating lease liabilities Lease liabilities 16,920 16,474 Total lease liabilities $ 66,297 $ 65,513 The following table presents the future undiscounted payments associated with lease liabilities as of August 31, 2024 Operating Finance leases leases 2025 $ 4,775 $ 3,299 2026 6,089 4,398 2027 5,439 4,398 2028 4,540 4,398 Thereafter 6,139 78,781 Total minimum lease payments $ 26,982 $ 95,274 Imputed interest (5,538 ) (50,421 ) Obligations recognized $ 21,444 $ 44,853

Note 5 - Intangible Assets

Note 5 - Intangible Assets	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	Note 5. Intangible assets consisted of the following items: August 31, May 31, 2024 2024 Customer relationships & distribution channel $ 609,728 $ 603,939 Licenses, permits & applications 371,507 368,057 Non-compete agreements 12,441 12,403 Intellectual property, trademarks, knowhow & brands 616,721 608,672 1,610,397 $ 1,593,071 Less: accumulated amortization (285,785 ) (261,758 ) Less: impairments (415,844 ) (415,844 ) Total $ 908,768 $ 915,469 Included in Licenses, permits & applications was $185,636 of indefinite-lived intangible assets as of August 31, 2024 May 31, 2024 Expected future amortization expense for intangible assets as of August 31, 2024 Amortization 2025 (remaining nine months) $ 55,822 2026 74,430 2027 74,430 2028 74,430 2029 74,430 Thereafter 369,590 Total $ 723,132

Note 6 - Goodwill

Note 6 - Goodwill	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Goodwill Disclosure [Text Block]	Note 6. The following table shows the carrying amount of goodwill by reporting units: August 31, May 31, Reporting Unit 2024 2024 Cannabis $ 2,640,669 $ 2,640,669 Distribution 4,458 4,458 Beverage alcohol 120,802 120,802 Wellness 77,470 77,470 Effect of foreign exchange 8,746 7,916 Impairments (842,431 ) (842,431 ) Total $ 2,009,714 $ 2,008,884

Note 7 - Business Acquisitions

Note 7 - Business Acquisitions	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Business Combination Disclosure [Text Block]	Note 7. Business a cquisitions Acquisition of Craft Beverage Business Portfolio On September 29, 2023, eight 10 The Company is in the process of assessing the fair value of the net assets acquired and, as a result, the fair value may Amount Consideration Cash consideration $ 83,658 Net assets acquired Current assets Cash and cash equivalents 77 Inventory 21,493 Prepaids and other current assets 573 Long-term assets Capital assets 76,114 Finance lease, right-of-use assets 45,496 Operating lease, right-of-use assets 7,677 Other assets 108 Total assets 151,538 Current liabilities Accounts payable and accrued liabilities 14,706 Current portion of finance lease liabilities 1,031 Current portion of operating lease liabilities 1,408 Long - term liabilities Finance lease liabilities 44,465 Operating lease liabilities 6,270 Total liabilities 67,880 Total net assets acquired 83,658 In the event that the Craft Acquisition had occurred on June 1, 2022, $nil three August 31, 2024 2023, $nil three August 31, 2024 2023, not

Note 8 - Convertible Notes Rece

Note 8 - Convertible Notes Receivable	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 8. Convertible notes receivable is comprised of the following: August 31, May 31, 2024 2024 MedMen Convertible Note 32,000 32,000 Deduct - current portion — — Total convertible notes receivable, non current portion $ 32,000 $ 32,000 MedMen Convertible Note On August 31, 2021, August 17, 2028, During the year ended May 31, 2024, January 23, 2024 no three August 31, 2024 The Company did not May 31, 2024, not three August 31, 2024

Note 9 - Long Term Investments

Note 9 - Long Term Investments	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Investment [Text Block]	Note 9. Long term investments consisted of the following: August 31, May 31, 2024 2024 Equity investments measured at fair value $ 2,353 $ 2,359 Equity investments under measurement alternative 5,500 5,500 Total $ 7,853 $ 7,859

Note 10 - Bank Indebtedness

Note 10 - Bank Indebtedness	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Short-Term Debt [Text Block]	Note 10. Aphria Inc., a subsidiary of the Company, has an operating line of credit in the amount of C$1,000, August 31, 2024 not 265 CC Pharma GmbH, a subsidiary of the Company, has two €7,000 €500. August 31, 2024 €7,395 €7,500. €7,000 €500 American Beverage Crafts Group Inc. ("ABC Group"), a subsidiary of the Company, has a revolving credit facility of $30,000, which bears interest at SOFR plus an applicable margin. As of August 31, 2024

Note 11 - Accounts Payable and

Note 11 - Accounts Payable and Accrued Liabilities	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	Note 11. Accounts payable and accrued liabilities are comprised of: August 31, May 31, 2024 2024 Trade payables $ 101,868 $ 105,392 Accrued liabilities 90,899 92,424 Litigation accrual 24,413 24,378 Accrued payroll and employment related taxes 10,279 6,154 Income taxes payable 973 4,092 Accrued interest 3,359 4,217 Sales taxes payable 4,355 5,300 Total $ 236,146 $ 241,957

Note 12 - Long-term Debt

Note 12 - Long-term Debt	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Long-Term Debt [Text Block]	Note 12. The following table sets forth the net carrying amount of long-term debt instruments: August 31, May 31, 2024 2024 Credit facility - C$ 66,000 3 10 November 2025 $ 38,480 $ 39,420 Term loan - C$ 25,000 1.00 5 15 181 July 2033 10,154 10,212 Term loan - C$ 25,000 1.00 5 15 196 July 2033 12,406 12,422 Term loan - C$ 1,250 1.50 5 10 12 August 2026 245 263 Mortgage payable - C$ 3,750 1.50 5 20 23 August 2026 2,111 2,089 Term loan ‐ € 1,500 2.00 5 94 April 2025 320 417 Term loan ‐ € 3,500 4.59 5 52 August 2028 3,030 3,151 Mortgage payable - $ 22,635 1.5 10 57 October 2030 19,969 20,066 Term loan - $ 90,000 5 875 1,750 June 2028 85,500 86,626 Carrying amount of long-term debt 172,215 174,666 Unamortized financing fees (875 ) (808 ) Net carrying amount 171,340 173,858 Less principal portion included in current liabilities (16,072 ) (15,506 ) Total noncurrent portion of long-term debt $ 155,268 $ 158,352

Note 13 - Convertible Debenture

Note 13 - Convertible Debentures Payable	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Convertible Debentures [Text Block]	Note 13. The following table sets forth the net carrying amount of the convertible debentures payable: August 31, May 31, 2024 2024 5.20% $ 132,650 $ 129,583 5.25% — 330 Total 132,650 129,913 Deduct - current portion — 330 Total convertible debentures payable, non current portion $ 132,650 $ 129,583 TLRY 27 August 31, May 31, 2024 2024 5.20 $ 172,500 $ 172,500 Unamortized discount (39,850 ) (42,917 ) Net carrying amount $ 132,650 $ 129,583 The TLRY 27 May 30, 2023 June 9, 2023 27 27 June 15 December 15 June 15, 2027, 27 not 23 24, 27 second June 15, 2027. 27 The TLRY 27 not June 20, 2025 may 27 27 may 27 27 not 27 27 During the three August 31, 2024 three August 31, 2023, APHA 24 August 31, May 31, 2024 2024 5.25 $ — $ 350,000 Debt settlement — (349,670 ) Fair value adjustment — — Net carrying amount $ — $ 330 The APHA 24 April 2019, June 1 December 1 June 1, 2024 ( 24 June 1, 2024, 24

Note 14 - Warrant Liability

Note 14 - Warrant Liability	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Warrants [Text Block]	Note 14. As of August 31, 2024 May 31, 2024, September 17, 2025. one The warrants contain anti-dilution price protection features, which adjust the exercise price of the warrants if the Company subsequently issues common stock at a price lower than the exercise price of the warrants. In the event additional warrants or convertible debt are issued with a lower and/or variable exercise price, the exercise price of the warrants will be adjusted accordingly. During the nine August 31, 2024 may may 3 9 1933 not may may may not The Company estimated the fair value of warrants outstanding as of August 31, 2024 3 Expected volatility is based on both historical and implied volatility of the Company’s common stock.

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Equity [Text Block]	Note 15. Issued and outstanding As of August 31, 2024 nil During the three August 31, 2024 a) 36,693,307 shares under its At-the-Market (“ATM”) program generating gross proceeds of $68,279. The Company paid $1,807 in commissions and other fees associated with these issuances, with net proceeds of $66,472. b) 6,826,148 shares in connection with the exercise of previously awarded stock-based compensation awards. During the three August 31, 2024 $nil three August 31, 2023 not not three August 31, 2024 August 31, 2023 For the three months ended August 31, August 31, 2024 2023 RSUs 6,917 8,257 Total $ 6,917 $ 8,257

Note 16 - Accumulated Other Com

Note 16 - Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	Note 16. Accumulated other comprehensive loss includes the following components: Foreign currency translation gain (loss) Total Balance May 31, 2023 $ (46,610 ) $ (46,610 ) Other comprehensive loss 3,049 3,049 Balance August 31, 2023 $ (43,561 ) $ (43,561 ) Balance May 31, 2024 $ (43,499 ) $ (43,499 ) Other comprehensive loss 3,622 3,622 Balance August 31, 2024 $ (39,877 ) $ (39,877 )

Note 17 - Non-controlling Inter

Note 17 - Non-controlling Interests	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Noncontrolling Interest Disclosure [Text Block]	Note 17. The following tables summarize the information relating to the following subsidiaries of the Company in which there is non-controlling interest; SH Acquisition (68%), CC Pharma Nordic ApS (75%), Aphria Diamond (51%), and ColCanna S.A.S. (90%) before intercompany eliminations. Summary of balance sheet information of the entities in which there is a non-controlling interest as of August 31, 2024 SH CC Pharma Aphria ColCanna August 31, Acquisition Nordic ApS Diamond S.A.S. 2024 Current assets $ — $ 14 $ 108,030 $ 11 $ 108,055 Non-current assets 32,000 — 123,694 3,355 159,049 Current liabilities — (17 ) (133,014 ) (6,993 ) (140,024 ) Non-current liabilities — — (23,359 ) (1,451 ) (24,810 ) Net assets $ 32,000 $ (3 ) $ 75,351 $ (5,078 ) $ 102,270 Summary of balance sheet information of the entities in which there is a non-controlling interest as of May 31, 2024 SH CC Pharma Aphria ColCanna May 31, Acquisition Nordic ApS Diamond S.A.S. 2024 Current assets $ — $ 12 $ 95,720 $ 3 $ 95,735 Non-current assets 32,000 — 124,675 3,637 160,312 Current liabilities — (9 ) (130,945 ) (6,913 ) (137,867 ) Non-current liabilities — — (24,482 ) (1,452 ) (25,934 ) Net assets $ 32,000 $ 3 $ 64,968 $ (4,725 ) $ 92,246 Summary of income statement information of the entities in which there is a non-controlling interest for the three August 31, 2024 SH CC Pharma Aphria ColCanna August 31, Acquisition Nordic ApS Diamond S.A.S. 2024 Revenue $ — $ — $ 18,558 $ — $ 18,558 Total expenses — 5 9,216 630 9,851 Net (loss) income — (5 ) 9,342 (630 ) 8,707 Other comprehensive (loss) income — (1 ) 1,041 277 1,317 Net comprehensive (loss) income $ — $ (6 ) $ 10,383 $ (353 ) $ 10,024 Non-controlling interest % 32 % 25 % 49 % 10 % NA Comprehensive (loss) income attributable to NCI — (2 ) 5,088 (35 ) 5,051 Net comprehensive (loss) income attributable to NCI $ — $ (2 ) $ 5,088 $ (35 ) $ 5,051 Summary of income statement information of the entities in which there is a non-controlling interest for the three August 31, 2023: SH CC Pharma Aphria ColCanna August 31, Acquisition Nordic ApS Diamond S.A.S. 2023 Revenue $ — $ — $ 39,230 $ — $ 39,230 Total expenses — 35 15,636 216 15,887 Net (loss) income — (35 ) 23,594 (216 ) 23,343 Other comprehensive (loss) income — (20 ) 533 (345 ) 168 Net comprehensive (loss) income $ — $ (55 ) $ 24,127 $ (561 ) $ 23,511 Non-controlling interest % 32 % 25 % 49 % 10 % NA Comprehensive (loss) income attributable to NCI — (14 ) 11,822 (56 ) 11,752 Additional income attributable to NCI — — 4,070 — 4,070 Net comprehensive (loss) income attributable to NCI $ — $ (14 ) $ 15,892 $ (56 ) $ 15,822

Note 18 - Income Taxes

Note 18 - Income Taxes	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 18. The determination of the Company’s overall effective tax rate requires significant judgment, the use of estimates, and the interpretation and application of complex tax laws. The effective tax rate reflects the income earned and taxed in various United States federal, state, and foreign jurisdictions. Tax law changes, increases, and decreases in temporary and permanent differences between book and tax items, valuation allowances against the deferred tax assets, stock compensation, and the Company’s change in income in each jurisdiction all affect the overall effective tax rate. It is the Company’s practice to recognize interest and penalties related to uncertain tax positions in income tax expense. The Company reported income tax expense of $886 for the three August 31, 2024 three August 31, 2023. no

Note 19 - Commitments and Conti

Note 19 - Commitments and Contingencies	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 19. Purchase and other commitments The Company has payments on long-term debt, refer to Note 12 13 Total 2025 2026 2027 2028 Thereafter Long-term debt repayment $ 172,215 $ 16,072 $ 42,563 $ 12,604 $ 66,762 $ 34,214 Convertible debentures payable 172,500 — — 172,500 — — Material purchase obligations 67,142 39,615 27,527 — — Construction commitments 431 431 — — — — Total $ 412,288 $ 56,118 $ 70,090 $ 185,104 $ 66,762 $ 34,214 Legal proceedings In the ordinary course of business, we are at times subject to various legal proceedings and disputes, including the proceedings specifically discussed below. We assess our liabilities and contingencies in connection with outstanding legal proceedings utilizing the latest information available. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our consolidated financial statements. These legal reserves may not not not not may There have been no 10 May 31, 2024 September 30, 2024: Authentic Brands Group Related Class Action (New York, United States) On May 4, 2020, 10 20 1934 January 15, 2019, March 2, 2020. On September 27, 2021, December 3, 2021, second second February 2, 2022. second one September 27, 2023, On September 30, 2024, In the Matter of an Arbitration Between: K. Dickson v. Tilray, Inc. In 2021, On March 17, 2023, May 23, 2023, February 27, 2024, March 15, 2024, August 8, 2024, August 12, 2024, September 27, 2024. Summary of litigation accruals As described in Note 11 August 31, 2024 May 31, 2024,

Note 20 - Net Revenue

Note 20 - Net Revenue	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 20. The Company reports net revenue in four Net revenue is comprised of: For the three months ended August 31, August 31, 2024 2023 Beverage alcohol revenue $ 59,163 $ 25,339 Beverage alcohol excise taxes (3,191 ) (1,177 ) Net beverage alcohol revenue 55,972 24,162 Cannabis revenue 81,194 96,884 Cannabis excise taxes (19,945 ) (26,551 ) Net cannabis revenue 61,249 70,333 Distribution revenue 68,071 69,157 Wellness revenue 14,752 13,297 Total $ 200,044 $ 176,949

Note 21 - Cost of Goods Sold

Note 21 - Cost of Goods Sold	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Cost of Goods Sold [Text Block]	Note 21. Cost of goods sold is comprised of: For the three months ended August 31, August 31, 2024 2023 Beverage alcohol costs $ 33,050 $ 11,266 Cannabis costs 37,054 50,517 Distribution costs 60,138 61,468 Wellness costs 10,096 9,502 Total $ 140,338 $ 132,753

Note 22 - General and Administr

Note 22 - General and Administrative Expenses	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
General and Administrative Expenses [Text Block]	Note 22. General and administrative expenses are comprised of: For the three months ended August 31, August 31, 2024 2023 Salaries and wages $ 21,567 $ 16,775 Office and general 9,260 8,168 Stock-based compensation 6,917 8,257 Insurance 2,455 3,849 Professional fees 1,178 1,499 (Gain) loss on sale of capital assets (26 ) 3 Travel and accommodation 1,493 1,107 Rent 1,269 858 Total $ 44,113 $ 40,516

Note 23 - Restructuring Charges

Note 23 - Restructuring Charges	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Restructuring and Related Activities Disclosure [Text Block]	Note 23. In connection with the execution of our acquisition strategy and strategic transactions, the Company has incurred restructuring and exit costs associated with the integration efforts of these non-recurring transactions. The Company recognized $4,247 of restructuring charges for the three August 31, 2024 August 31, 2024 Within the Cannabis segment, our restructuring costs predominantly related to the HEXO acquisition, which are expected to be completed within 24 June 2023. three August 31, 2024 third May 31, 2024. Within the Distribution segment, the Company recognized $121 of restructuring charges for its Argentinean pharmacy business. Within the beverage alcohol segment, the Company recognized $123 of employee termination benefits through the integration of the Craft acquisition. Lastly, for the three August 31, 2024

Note 24 - Non-operating Income

Note 24 - Non-operating Income (Expense), Net	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Other Nonoperating Income and Expense [Text Block]	Note 24. Non-operating income (expense), net is comprised of: For the three months ended August 31, August 31, 2024 2023 Change in fair value of convertible debenture payable $ — $ (2,147 ) Change in fair value of warrant liability 696 (8,198 ) Foreign exchange gain (loss) 11,881 6,267 Loss on long-term investments (39 ) (109 ) Other non-operating (losses) gains, net 108 (215 ) Total $ 12,646 $ (4,402 )

Note 25 - Fair Value Measuremen

Note 25 - Fair Value Measurements	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	Note 25. Fair value measurements Financial instruments The Company has classified its financial instruments as described in Note 3 The carrying values of marketable securities, accounts receivable, bank indebtedness and accounts payable and accrued liabilities approximate their fair values due to their short periods to maturity. On August 31, 2024 May 31, 2024 The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of August 31, 2024 May 31, 2024 August 31, Level 1 Level 2 Level 3 2024 Financial assets Cash and cash equivalents $ 205,186 $ — $ — $ 205,186 Marketable securities 74,869 — — 74,869 Convertible notes receivable — — 32,000 32,000 Equity investments measured at fair value 891 1,462 5,500 7,853 Financial liabilities Warrant liability — — (2,557 ) (2,557 ) Contingent consideration — — (15,000 ) (15,000 ) APHA 24 Convertible debenture — — — — Total recurring fair value measurements $ 280,946 $ 1,462 $ 19,943 $ 302,351 May 31, Level 1 Level 2 Level 3 2024 Financial assets Cash and cash equivalents $ 228,340 $ — $ — $ 228,340 Marketable Securities 32,182 — — 32,182 Convertible notes receivable — — 32,000 32,000 Equity investments measured at fair value 919 1,440 5,500 7,859 Financial liabilities Warrant liability — — (3,253 ) (3,253 ) Contingent consideration — — (15,000 ) (15,000 ) APHA 24 Convertible debenture — — (330 ) (330 ) Total recurring fair value measurements $ 261,441 $ 1,440 $ 18,917 $ 281,798 The Company’s financial assets and liabilities required to be measured on a recurring basis are its convertible notes receivable, equity investments measured at fair value, convertible debentures measured at fair value, acquisition-related contingent consideration, and warrant liability. Convertible notes receivable and long-term investments are recorded at fair value. The estimated fair value is determined using, among others, the Black Scholes option pricing model, probability of legalization and is classified as Level 3. Convertible debentures payable are recorded at fair value when elected or required under US GAAP. Specifically, the APHA 24 3. Certain equity investments recorded at fair value have quoted prices in active markets for identical assets and are classified as Level 1. 2 3. The warrants associated with the warrant liability are classified as Level 3 A portion of the consideration to be paid in connection the Company’s acquisition of Montauk Brewing is contingent upon the achievement of certain financial measures as of December 2025, not 3. During the three August 31, 2024, $nil August 31, 2023 not The balances of assets and liabilities categorized within Level 3 APHA 24 Convertible Equity Warrant Contingent Convertible notes receivable Investments Liability Consideration Debt Balance, May 31, 2024 $ 32,000 $ 5,500 $ (3,253 ) $ (15,000 ) $ (330 ) Additions/(Repayments) — — — — 330 Redemption — — — — — Unrealized gain (loss) on fair value — — 696 — — Impairments — — — — — Balance, August 31, 2024 $ 32,000 $ 5,500 $ (2,557 ) $ (15,000 ) $ — The unrealized gain (loss) on fair value for the convertible debenture, the warrant liability, contingent consideration, and debt securities classified under available-for-sale method is recognized in the consolidated statements of loss and comprehensive loss using the following inputs: Significant Valuation unobservable Financial asset / financial liability technique input Inputs Warrant liability Black-Scholes Volatility, 50% expected life (in years) 1.0 Contingent consideration Discounted cash flows Discount rate, 11% Probability of achievement 100% and 0% Items measured at fair value on a non-recurring basis The Company's prepaids and other current assets, long lived assets, including property and equipment, goodwill and intangible assets are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable. There have been no

Note 26 - Segment Reporting

Note 26 - Segment Reporting	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 26. Segment reporting Information reported to the Chief Operating Decision Maker (“CODM”) for the purpose of resource allocation and assessment of segment performance focuses on the nature of the operations. The Company operates in four 1 2 3 4 Operating segments have not no not Segment gross profit from external customers: For the three months ended August 31, August 31, 2024 2023 Beverage alcohol Net beverage alcohol revenue $ 55,972 $ 24,162 Beverage alcohol costs 33,050 11,266 Beverage alcohol gross profit 22,922 12,896 Cannabis Net cannabis revenue 61,249 70,333 Cannabis costs 37,054 50,517 Cannabis gross profit 24,195 19,816 Distribution Distribution revenue 68,071 69,157 Distribution costs 60,138 61,468 Distribution gross profit 7,933 7,689 Wellness Wellness revenue 14,752 13,297 Wellness costs 10,096 9,502 Wellness gross profit $ 4,656 $ 3,795 Channels of Cannabis revenue were as follows: For the three months ended August 31, August 31, 2024 2023 Revenue from Canadian medical cannabis $ 6,261 $ 6,142 Revenue from Canadian adult-use cannabis 57,235 71,195 Revenue from wholesale cannabis 5,507 5,295 Revenue from international cannabis 12,191 14,252 Less excise taxes (19,945 ) (26,551 ) Total $ 61,249 $ 70,333 Included in revenue from Canadian adult-use cannabis is $nil three August 31, 2024 Geographic net revenue: For the three months ended August 31, August 31, 2024 2023 USA $ 63,880 $ 31,489 Canada 55,905 62,032 EMEA 77,672 79,704 Rest of World 2,587 3,724 Total $ 200,044 $ 176,949 Geographic capital assets: August 31, May 31, 2024 2024 USA $ 140,900 $ 141,314 Canada 312,432 313,359 EMEA 98,433 99,921 Rest of World 3,371 3,653 Total $ 555,136 $ 558,247 Major customers are defined as customers that are materially significant to the Company’s annual revenues. For the three August 31, 2024 2023 no

Note 27 - Subsequent Events

Note 27 - Subsequent Events	3 Months Ended
	Aug. 31, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	Note 27. Subsequent Events Effective September 1, 2024, four As part of the Company's ATM Program, from September 1, 2024 September 10, 2024, On September 12, 2024, 27 27 On September 17, 2024, $23,792

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Aug. 31, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	5. In July 2024, 2025 10 July 30, 2024. August 2024 The Company amended and restated its form of “Executive Retention Agreements” on August 15, 2024. August 15, 2024, August 31, 2025 ( August 31, 2025, not 10
Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Aug. 31, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of consolidation Subsidiaries are entities controlled by the Company. Control exists when the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. The financial statements of all subsidiaries are included in the Financial Statements from the date that control commences until the date that control ceases. All intercompany balances and transactions have been eliminated on consolidation. A complete list of our subsidiaries that existed as of our most recent fiscal year end is included in the Annual Report.
Financing Receivable [Policy Text Block]	Convertible notes receivable Convertible notes receivable includes various investments in which the Company has the right, or potential right to convert the indenture into common stock of the investee and are classified as available-for-sale and are recorded at fair value. Unrealized gains and losses during the year, net of the related tax effect, are excluded from income and reflected in other comprehensive income (loss), and the cumulative effect is reported as a separate component of shareholders' equity until realized. We use judgement to assess convertible notes receivables for impairment at each measurement date. Convertible notes receivables are impaired when a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of loss and comprehensive loss and a new cost basis for the investment is established. We also evaluate whether there is a plan to sell the security, or it is more likely than not
Earnings Per Share, Policy [Policy Text Block]	Earnings (loss) per share Basic earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the weighted average number of common shares outstanding during the year. Diluted earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the sum of the weighted average number of common shares and the number of dilutive potential common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options, warrants, and RSUs and the incremental shares issuable upon conversion of the convertible debentures and similar instruments. Shares of common stock outstanding under the share lending arrangement entered into in conjunction with the TLRY 27 13 In computing diluted earnings (loss) per share, common share equivalents are not three August 31, 2024 August 31, 2023
New Accounting Pronouncements, Policy [Policy Text Block]	New accounting pronouncements not In August 2023, 2023 05, Business Combination - Joint Venture Formations 805 60 2023 05” 2023 05 June 1, 2026. In October 2023, 2023 06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, X June 30, 2027, not X not In December 2023, 2023 09, Income Taxes (Topic 740 2023 09 June 1, 2025. New accounting pronouncements recently adopted In November 2023, 2023 07, Segment Reporting (Topic 280 2023 07 May 31, 2025 10 On March 21, 2024, 2024 01, 718 718 10 15 3 2024 01 June 1, 2024 no

Note 2 - Inventory (Tables)

Note 2 - Inventory (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	August 31, May 31, 2024 2024 Beverage alcohol inventory 58,784 $ 52,831 Plants 16,333 13,828 Dried cannabis 107,290 108,721 Cannabis derivatives 7,306 4,504 Cannabis vapes 4,858 4,132 Packaging and other inventory items 20,270 22,115 Distribution inventory 38,202 35,645 Wellness inventory 11,252 10,311 Total $ 264,295 $ 252,087

Note 3 - Capital Assets (Tables

Note 3 - Capital Assets (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Property, Plant and Equipment [Table Text Block]	August 31, May 31, 2024 2024 Land $ 45,165 $ 45,577 Production facilities 375,345 369,630 Equipment 262,876 258,532 Leasehold improvements 19,463 19,377 Finance lease, right-of-use assets 43,429 43,993 Construction in progress 12,516 10,713 $ 758,794 $ 747,822 Less: accumulated amortization (203,658 ) (189,575 ) Total $ 555,136 $ 558,247
Disclosure of Long-Lived Assets Held-for-Sale [Table Text Block]	August 31, May 31, 2024 2024 Land $ 970 $ 954 Production facility 25,010 24,682 Equipment 6,556 6,438 $ 32,536 $ 32,074

Note 4 - Leases (Tables)

Note 4 - Leases (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Lease Related Assets and Liabilities [Table Text Block]	August 31, May 31, Classification on Balance Sheet 2024 2024 Assets Finance lease, right-of-use assets Capital assets $ 43,429 $ 43,993 Operating lease, right-of-use assets Operating lease, right-of-use assets 17,176 16,101 Total right-of-use asset $ 60,605 $ 60,094 Liabilities Current: Current portion of finance lease liabilities Current portion of lease liabilities $ 1,116 $ 1,092 Current portion of operating lease liabilities Current portion of lease liabilities 4,524 3,999 Non-current: Finance lease liabilities Lease liabilities 43,737 43,948 Operating lease liabilities Lease liabilities 16,920 16,474 Total lease liabilities $ 66,297 $ 65,513
Lessee, Operating and Finance Lease, Liabilities, to be Paid, Maturity [Table Text Block]	Operating Finance leases leases 2025 $ 4,775 $ 3,299 2026 6,089 4,398 2027 5,439 4,398 2028 4,540 4,398 Thereafter 6,139 78,781 Total minimum lease payments $ 26,982 $ 95,274 Imputed interest (5,538 ) (50,421 ) Obligations recognized $ 21,444 $ 44,853

Note 5 - Intangible Assets (Tab

Note 5 - Intangible Assets (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	August 31, May 31, 2024 2024 Customer relationships & distribution channel $ 609,728 $ 603,939 Licenses, permits & applications 371,507 368,057 Non-compete agreements 12,441 12,403 Intellectual property, trademarks, knowhow & brands 616,721 608,672 1,610,397 $ 1,593,071 Less: accumulated amortization (285,785 ) (261,758 ) Less: impairments (415,844 ) (415,844 ) Total $ 908,768 $ 915,469
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Amortization 2025 (remaining nine months) $ 55,822 2026 74,430 2027 74,430 2028 74,430 2029 74,430 Thereafter 369,590 Total $ 723,132

Note 6 - Goodwill (Tables)

Note 6 - Goodwill (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Goodwill [Table Text Block]	August 31, May 31, Reporting Unit 2024 2024 Cannabis $ 2,640,669 $ 2,640,669 Distribution 4,458 4,458 Beverage alcohol 120,802 120,802 Wellness 77,470 77,470 Effect of foreign exchange 8,746 7,916 Impairments (842,431 ) (842,431 ) Total $ 2,009,714 $ 2,008,884

Note 7 - Business Acquisitions

Note 7 - Business Acquisitions (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Amount Consideration Cash consideration $ 83,658 Net assets acquired Current assets Cash and cash equivalents 77 Inventory 21,493 Prepaids and other current assets 573 Long-term assets Capital assets 76,114 Finance lease, right-of-use assets 45,496 Operating lease, right-of-use assets 7,677 Other assets 108 Total assets 151,538 Current liabilities Accounts payable and accrued liabilities 14,706 Current portion of finance lease liabilities 1,031 Current portion of operating lease liabilities 1,408 Long - term liabilities Finance lease liabilities 44,465 Operating lease liabilities 6,270 Total liabilities 67,880 Total net assets acquired 83,658

Note 8 - Convertible Notes Re_2

Note 8 - Convertible Notes Receivable (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	August 31, May 31, 2024 2024 MedMen Convertible Note 32,000 32,000 Deduct - current portion — — Total convertible notes receivable, non current portion $ 32,000 $ 32,000

Note 9 - Long Term Investments

Note 9 - Long Term Investments (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]	August 31, May 31, 2024 2024 Equity investments measured at fair value $ 2,353 $ 2,359 Equity investments under measurement alternative 5,500 5,500 Total $ 7,853 $ 7,859

Note 11 - Accounts Payable an_2

Note 11 - Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	August 31, May 31, 2024 2024 Trade payables $ 101,868 $ 105,392 Accrued liabilities 90,899 92,424 Litigation accrual 24,413 24,378 Accrued payroll and employment related taxes 10,279 6,154 Income taxes payable 973 4,092 Accrued interest 3,359 4,217 Sales taxes payable 4,355 5,300 Total $ 236,146 $ 241,957

Note 12 - Long-term Debt (Table

Note 12 - Long-term Debt (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Long-Term Debt Instruments [Table Text Block]	August 31, May 31, 2024 2024 Credit facility - C$ 66,000 3 10 November 2025 $ 38,480 $ 39,420 Term loan - C$ 25,000 1.00 5 15 181 July 2033 10,154 10,212 Term loan - C$ 25,000 1.00 5 15 196 July 2033 12,406 12,422 Term loan - C$ 1,250 1.50 5 10 12 August 2026 245 263 Mortgage payable - C$ 3,750 1.50 5 20 23 August 2026 2,111 2,089 Term loan ‐ € 1,500 2.00 5 94 April 2025 320 417 Term loan ‐ € 3,500 4.59 5 52 August 2028 3,030 3,151 Mortgage payable - $ 22,635 1.5 10 57 October 2030 19,969 20,066 Term loan - $ 90,000 5 875 1,750 June 2028 85,500 86,626 Carrying amount of long-term debt 172,215 174,666 Unamortized financing fees (875 ) (808 ) Net carrying amount 171,340 173,858 Less principal portion included in current liabilities (16,072 ) (15,506 ) Total noncurrent portion of long-term debt $ 155,268 $ 158,352

Note 13 - Convertible Debentu_2

Note 13 - Convertible Debentures Payable (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Convertible Debt [Table Text Block]	August 31, May 31, 2024 2024 5.20% $ 132,650 $ 129,583 5.25% — 330 Total 132,650 129,913 Deduct - current portion — 330 Total convertible debentures payable, non current portion $ 132,650 $ 129,583 August 31, May 31, 2024 2024 5.20 $ 172,500 $ 172,500 Unamortized discount (39,850 ) (42,917 ) Net carrying amount $ 132,650 $ 129,583 August 31, May 31, 2024 2024 5.25 $ — $ 350,000 Debt settlement — (349,670 ) Fair value adjustment — — Net carrying amount $ — $ 330

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 RSUs 6,917 8,257 Total $ 6,917 $ 8,257

Note 16 - Accumulated Other C_2

Note 16 - Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Foreign currency translation gain (loss) Total Balance May 31, 2023 $ (46,610 ) $ (46,610 ) Other comprehensive loss 3,049 3,049 Balance August 31, 2023 $ (43,561 ) $ (43,561 ) Balance May 31, 2024 $ (43,499 ) $ (43,499 ) Other comprehensive loss 3,622 3,622 Balance August 31, 2024 $ (39,877 ) $ (39,877 )

Note 17 - Non-controlling Int_2

Note 17 - Non-controlling Interests (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Condensed Balance Sheet [Table Text Block]	SH CC Pharma Aphria ColCanna August 31, Acquisition Nordic ApS Diamond S.A.S. 2024 Current assets $ — $ 14 $ 108,030 $ 11 $ 108,055 Non-current assets 32,000 — 123,694 3,355 159,049 Current liabilities — (17 ) (133,014 ) (6,993 ) (140,024 ) Non-current liabilities — — (23,359 ) (1,451 ) (24,810 ) Net assets $ 32,000 $ (3 ) $ 75,351 $ (5,078 ) $ 102,270 SH CC Pharma Aphria ColCanna May 31, Acquisition Nordic ApS Diamond S.A.S. 2024 Current assets $ — $ 12 $ 95,720 $ 3 $ 95,735 Non-current assets 32,000 — 124,675 3,637 160,312 Current liabilities — (9 ) (130,945 ) (6,913 ) (137,867 ) Non-current liabilities — — (24,482 ) (1,452 ) (25,934 ) Net assets $ 32,000 $ 3 $ 64,968 $ (4,725 ) $ 92,246
Condensed Income Statement [Table Text Block]	SH CC Pharma Aphria ColCanna August 31, Acquisition Nordic ApS Diamond S.A.S. 2024 Revenue $ — $ — $ 18,558 $ — $ 18,558 Total expenses — 5 9,216 630 9,851 Net (loss) income — (5 ) 9,342 (630 ) 8,707 Other comprehensive (loss) income — (1 ) 1,041 277 1,317 Net comprehensive (loss) income $ — $ (6 ) $ 10,383 $ (353 ) $ 10,024 Non-controlling interest % 32 % 25 % 49 % 10 % NA Comprehensive (loss) income attributable to NCI — (2 ) 5,088 (35 ) 5,051 Net comprehensive (loss) income attributable to NCI $ — $ (2 ) $ 5,088 $ (35 ) $ 5,051 SH CC Pharma Aphria ColCanna August 31, Acquisition Nordic ApS Diamond S.A.S. 2023 Revenue $ — $ — $ 39,230 $ — $ 39,230 Total expenses — 35 15,636 216 15,887 Net (loss) income — (35 ) 23,594 (216 ) 23,343 Other comprehensive (loss) income — (20 ) 533 (345 ) 168 Net comprehensive (loss) income $ — $ (55 ) $ 24,127 $ (561 ) $ 23,511 Non-controlling interest % 32 % 25 % 49 % 10 % NA Comprehensive (loss) income attributable to NCI — (14 ) 11,822 (56 ) 11,752 Additional income attributable to NCI — — 4,070 — 4,070 Net comprehensive (loss) income attributable to NCI $ — $ (14 ) $ 15,892 $ (56 ) $ 15,822

Note 19 - Commitments and Con_2

Note 19 - Commitments and Contingencies (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Contractual Obligation, Fiscal Year Maturity [Table Text Block]	Total 2025 2026 2027 2028 Thereafter Long-term debt repayment $ 172,215 $ 16,072 $ 42,563 $ 12,604 $ 66,762 $ 34,214 Convertible debentures payable 172,500 — — 172,500 — — Material purchase obligations 67,142 39,615 27,527 — — Construction commitments 431 431 — — — — Total $ 412,288 $ 56,118 $ 70,090 $ 185,104 $ 66,762 $ 34,214

Note 20 - Net Revenue (Tables)

Note 20 - Net Revenue (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 Beverage alcohol revenue $ 59,163 $ 25,339 Beverage alcohol excise taxes (3,191 ) (1,177 ) Net beverage alcohol revenue 55,972 24,162 Cannabis revenue 81,194 96,884 Cannabis excise taxes (19,945 ) (26,551 ) Net cannabis revenue 61,249 70,333 Distribution revenue 68,071 69,157 Wellness revenue 14,752 13,297 Total $ 200,044 $ 176,949

Note 21 - Cost of Goods Sold (T

Note 21 - Cost of Goods Sold (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Cost of Goods Sold [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 Beverage alcohol costs $ 33,050 $ 11,266 Cannabis costs 37,054 50,517 Distribution costs 60,138 61,468 Wellness costs 10,096 9,502 Total $ 140,338 $ 132,753

Note 22 - General and Adminis_2

Note 22 - General and Administrative Expenses (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of General and Administrative Expenses [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 Salaries and wages $ 21,567 $ 16,775 Office and general 9,260 8,168 Stock-based compensation 6,917 8,257 Insurance 2,455 3,849 Professional fees 1,178 1,499 (Gain) loss on sale of capital assets (26 ) 3 Travel and accommodation 1,493 1,107 Rent 1,269 858 Total $ 44,113 $ 40,516

Note 24 - Non-operating Incom_2

Note 24 - Non-operating Income (Expense), Net (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Other Nonoperating Income (Expense) [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 Change in fair value of convertible debenture payable $ — $ (2,147 ) Change in fair value of warrant liability 696 (8,198 ) Foreign exchange gain (loss) 11,881 6,267 Loss on long-term investments (39 ) (109 ) Other non-operating (losses) gains, net 108 (215 ) Total $ 12,646 $ (4,402 )

Note 25 - Fair Value Measurem_2

Note 25 - Fair Value Measurements (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	August 31, Level 1 Level 2 Level 3 2024 Financial assets Cash and cash equivalents $ 205,186 $ — $ — $ 205,186 Marketable securities 74,869 — — 74,869 Convertible notes receivable — — 32,000 32,000 Equity investments measured at fair value 891 1,462 5,500 7,853 Financial liabilities Warrant liability — — (2,557 ) (2,557 ) Contingent consideration — — (15,000 ) (15,000 ) APHA 24 Convertible debenture — — — — Total recurring fair value measurements $ 280,946 $ 1,462 $ 19,943 $ 302,351 May 31, Level 1 Level 2 Level 3 2024 Financial assets Cash and cash equivalents $ 228,340 $ — $ — $ 228,340 Marketable Securities 32,182 — — 32,182 Convertible notes receivable — — 32,000 32,000 Equity investments measured at fair value 919 1,440 5,500 7,859 Financial liabilities Warrant liability — — (3,253 ) (3,253 ) Contingent consideration — — (15,000 ) (15,000 ) APHA 24 Convertible debenture — — (330 ) (330 ) Total recurring fair value measurements $ 261,441 $ 1,440 $ 18,917 $ 281,798
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	APHA 24 Convertible Equity Warrant Contingent Convertible notes receivable Investments Liability Consideration Debt Balance, May 31, 2024 $ 32,000 $ 5,500 $ (3,253 ) $ (15,000 ) $ (330 ) Additions/(Repayments) — — — — 330 Redemption — — — — — Unrealized gain (loss) on fair value — — 696 — — Impairments — — — — — Balance, August 31, 2024 $ 32,000 $ 5,500 $ (2,557 ) $ (15,000 ) $ —
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	Significant Valuation unobservable Financial asset / financial liability technique input Inputs Warrant liability Black-Scholes Volatility, 50% expected life (in years) 1.0 Contingent consideration Discounted cash flows Discount rate, 11% Probability of achievement 100% and 0%

Note 26 - Segment Reporting (Ta

Note 26 - Segment Reporting (Tables)	3 Months Ended
	Aug. 31, 2024
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 Beverage alcohol Net beverage alcohol revenue $ 55,972 $ 24,162 Beverage alcohol costs 33,050 11,266 Beverage alcohol gross profit 22,922 12,896 Cannabis Net cannabis revenue 61,249 70,333 Cannabis costs 37,054 50,517 Cannabis gross profit 24,195 19,816 Distribution Distribution revenue 68,071 69,157 Distribution costs 60,138 61,468 Distribution gross profit 7,933 7,689 Wellness Wellness revenue 14,752 13,297 Wellness costs 10,096 9,502 Wellness gross profit $ 4,656 $ 3,795 For the three months ended August 31, August 31, 2024 2023 Revenue from Canadian medical cannabis $ 6,261 $ 6,142 Revenue from Canadian adult-use cannabis 57,235 71,195 Revenue from wholesale cannabis 5,507 5,295 Revenue from international cannabis 12,191 14,252 Less excise taxes (19,945 ) (26,551 ) Total $ 61,249 $ 70,333
Revenue from External Customers by Geographic Areas [Table Text Block]	For the three months ended August 31, August 31, 2024 2023 USA $ 63,880 $ 31,489 Canada 55,905 62,032 EMEA 77,672 79,704 Rest of World 2,587 3,724 Total $ 200,044 $ 176,949
Long-Lived Assets by Geographic Areas [Table Text Block]	August 31, May 31, 2024 2024 USA $ 140,900 $ 141,314 Canada 312,432 313,359 EMEA 98,433 99,921 Rest of World 3,371 3,653 Total $ 555,136 $ 558,247

Note 1 - Basis of Presentatio_2

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - shares	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities (in shares)	64,971,746	77,819,141
Restricted Stock Units (RSUs) [Member]
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (in shares)	23,411,577	21,202,933
Share-Based Payment Arrangement, Option [Member]
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (in shares)	3,359,144	6,325,348
Warrants [Member]
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (in shares)	6,210,000	7,847,219

Note 2 - Inventory - Schedule o

Note 2 - Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Inventory	$ 264,295	$ 252,087
Beverage Alcohol Inventory [Member]
Inventory	58,784	52,831
Plants [Member]
Inventory	16,333	13,828
Dried Cannabis [Member]
Inventory	107,290	108,721
Cannabis Derivatives [Member]
Inventory	7,306	4,504
Cannabis Vapes [Member]
Inventory	4,858	4,132
Packaging and Other Inventory Items [Member]
Inventory	20,270	22,115
Distribution Inventory [Member]
Inventory	38,202	35,645
Wellness Inventory [Member]
Inventory	$ 11,252	$ 10,311

Note 3 - Capital Assets - Sched

Note 3 - Capital Assets - Schedule of Capital Assets (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Capital assets, gross	$ 758,794	$ 747,822
Less: accumulated amortization	(203,658)	(189,575)
Total	555,136	558,247
Land [Member]
Capital assets, gross	45,165	45,577
Manufacturing Facility [Member]
Capital assets, gross	375,345	369,630
Equipment [Member]
Capital assets, gross	262,876	258,532
Leasehold Improvements [Member]
Capital assets, gross	19,463	19,377
Right of Use Assets [Member]
Capital assets, gross	43,429	43,993
Construction in Progress [Member]
Capital assets, gross	$ 12,516	$ 10,713

Note 3 - Capital Assets - Asset

Note 3 - Capital Assets - Assets Held for Sale (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Assets, Held for sale	$ 32,536	$ 32,074
Land [Member]
Assets, Held for sale	970	954
Production Facility [Member]
Assets, Held for sale	25,010	24,682
Equipment [Member]
Assets, Held for sale	$ 6,556	$ 6,438

Note 4 - Leases - Lease Related

Note 4 - Leases - Lease Related Assets and Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Finance lease, right-of-use assets	$ 43,429	$ 43,993
Operating lease, right-of-use assets	17,176	16,101
Total right-of-use asset	60,605	60,094
Current portion of finance lease liabilities	1,116	1,092
Current portion of operating lease liabilities	4,524	3,999
Finance lease liabilities	43,737	43,948
Operating lease liabilities	16,920	16,474
Total lease liabilities	$ 66,297	$ 65,513

Note 4 - Leases - Lease Relat_2

Note 4 - Leases - Lease Related Assets and Liabilities (Details) (Parentheticals) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Liabilities, Current [Abstract]
Operating and Finance Lease Liability, Current	$ 5,640	$ 5,091
Liabilities, Noncurrent [Abstract]
Operating and Finance Lease Liability, Noncurrent	$ 60,657	$ 60,422
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Operating and Finance Lease Liability, Current	Operating and Finance Lease Liability, Current
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Operating and Finance Lease Liability, Current	Operating and Finance Lease Liability, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Operating and Finance Lease Liability, Noncurrent	Operating and Finance Lease Liability, Noncurrent
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Operating and Finance Lease Liability, Noncurrent	Operating and Finance Lease Liability, Noncurrent

Note 4 - Leases - Schedule of M

Note 4 - Leases - Schedule of Maturity (Details) $ in Thousands	Aug. 31, 2024 USD ($)
2025, operating	$ 4,775
2025, finance	3,299
2026, operating	6,089
2026, finance	4,398
2027, operating	5,439
2027, finance	4,398
2028, operating	4,540
2028, finance	4,398
Thereafter, operating	6,139
Thereafter, finance	78,781
Total minimum lease payments, operating	26,982
Total minimum lease payments	95,274
Imputed interest, operating	(5,538)
Imputed interest	(50,421)
Obligations recognized, operating	21,444
Obligations recognized	$ 44,853

Note 5 - Intangible Assets (Det

Note 5 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Licenses, Permits and Applications [Member]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$ 185,636	$ 182,851

Note 5 - Intangible Assets - Sc

Note 5 - Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Cost	$ 1,610,397	$ 1,593,071
Less: accumulated amortization	(285,785)	(261,758)
Less: impairments	(415,844)	(415,844)
Total	908,768	915,469
Customer Relationships and Distribution Channel [Member]
Cost	609,728	603,939
Licenses, Permits and Applications [Member]
Cost	371,507	368,057
Noncompete Agreements [Member]
Cost	12,441	12,403
Intellectual Property, Trademarks, Know How and Brands [Member]
Cost	$ 616,721	$ 608,672

Note 5 - Intangible Assets- Sch

Note 5 - Intangible Assets- Schedule of Estimated Amortization Expense (Details) $ in Thousands	Aug. 31, 2024 USD ($)
2025 (remaining nine months)	$ 55,822
2026	74,430
2027	74,430
2028	74,430
2029	74,430
Thereafter	369,590
Total	$ 723,132

Note 6 - Goodwill - Carrying Am

Note 6 - Goodwill - Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Effect of foreign exchange	$ 8,746	$ 7,916
Impairments	(842,431)	(842,431)
Goodwill	2,009,714	2,008,884
Cannabis Segment [Member]
Goodwill, gross	2,640,669	2,640,669
Tilray Pharma [Member]
Goodwill, gross	4,458	4,458
Beverage Alcohol Business [Member]
Goodwill, gross	120,802	120,802
Wellness Business [Member]
Goodwill, gross	$ 77,470	$ 77,470

Note 7 - Business Acquisition_2

Note 7 - Business Acquisitions (Details Textual) - Craft Beverage Business Acquisition [Member] $ in Thousands		3 Months Ended
	Sep. 29, 2023 USD ($)	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)
Number of Brands Acquired	8
Payments to Acquire Businesses, Gross	$ 83,658
Working Capital Adjustment	$ 1,342
Business Acquisition, Pro Forma Revenue		$ 0	$ 41,000
Business Acquisition, Pro Forma Net Income (Loss)		$ 0	$ 3,000

Note 7 - Business Acquisition_3

Note 7 - Business Acquisitions - Assets Acquired and Liabilities Assumed (Details) $ in Thousands	Sep. 29, 2023 USD ($)
Finance lease, right-of-use assets	$ 45,496
Craft Beverage Business Acquisition [Member]
Cash consideration	83,658
Cash and cash equivalents	77
Inventory	21,493
Prepaids and other current assets	573
Capital assets	76,114
Operating lease, right-of-use assets	7,677
Other assets	108
Total assets	151,538
Accounts payable and accrued liabilities	14,706
Current portion of finance lease liabilities	1,031
Current portion of operating lease liabilities	1,408
Finance lease liabilities	44,465
Operating lease liabilities	6,270
Total liabilities	67,880
Total net assets acquired	$ 83,658

Note 8 - Convertible Notes Re_3

Note 8 - Convertible Notes Receivable (Details Textual) - USD ($) $ in Thousands		3 Months Ended
	Aug. 31, 2021	Aug. 31, 2024
MM Notes [Member]
Financing Receivable, before Allowance for Credit Loss, Total	$ 165,799
Notes Receivable, Interest Rate, Basis Spread on Variable Rate	6%
Notes Receivable, SOFR Floor	2.50%
Other-than-temporary Fair Value Loss, Convertible Notes Receivable		$ 42,681
MM Notes [Member] | Convertible Debt [Member]
Interest Income, Purchased Receivables		$ 0
Superhero Acquisition LP [Member]
Noncontrolling Interest, Ownership Percentage by Parent	68%	68%
The MM Notes and MM Warrants [Member]
Stock Issued During Period, Shares, Acquisitions (in shares)	9,817,061
Stock Issued During Period, Value, Acquisitions	$ 117,804

Note 8 - Convertible Notes Re_4

Note 8 - Convertible Notes Receivable - Schedule of Convertible Notes Receivable (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Deduct - current portion	$ 0	$ 0
Total convertible notes receivable, non current portion	32,000	32,000
MedMen Convertible Note [Member]
Total convertible notes receivable	$ 32,000	$ 32,000

Note 9 - Long-term Investments

Note 9 - Long-term Investments - Schedule of Long-term Investments (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Equity investments measured at fair value	$ 2,353	$ 2,359
Equity investments under measurement alternative	5,500	5,500
Total	$ 7,853	$ 7,859

Note 10 - Bank Indebtedness (De

Note 10 - Bank Indebtedness (Details Textual) $ in Thousands, $ in Thousands, € in Millions	3 Months Ended
	Aug. 31, 2024 USD ($)	Aug. 31, 2024 CAD ($)	Aug. 31, 2024 EUR (€)
Four Twenty Corporation [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 30,000
Long-Term Line of Credit, Total	$ 10,000
Line of Credit [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	75%
Line of Credit [Member] | Aphria Inc [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 1,000
Long-Term Line of Credit, Total		$ 0
Line of Credit [Member] | CC Pharma GmbH [Member]
Line of Credit Facility, Maximum Borrowing Capacity | €			€ 7.5
Number of Debt Instruments	2	2	2
Line of Credit [Member] | CC Pharma GmbH [Member] | Euro Short-Term Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	2.50%
Line of Credit [Member] | CC Pharma GmbH [Member] | Euro Interbank Offered Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	4%
Operating Line of Credit One [Member] | CC Pharma GmbH [Member]
Line of Credit Facility, Maximum Borrowing Capacity | €			€ 7
Operating Line of Credit Two [Member] | CC Pharma GmbH [Member]
Line of Credit Facility, Maximum Borrowing Capacity | €			€ 0.5
Long-Term Line of Credit, Total	$ 8,134	$ 7,395

Note 11 - Accounts Payable an_3

Note 11 - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Trade payables	$ 101,868	$ 105,392
Accrued liabilities	90,899	92,424
Litigation accrual	24,413	24,378
Accrued payroll and employment related taxes	10,279	6,154
Income taxes payable	973	4,092
Accrued interest	3,359	4,217
Sales taxes payable	4,355	5,300
Total	$ 236,146	$ 241,957

Note 12 - Long-term Debt - Net

Note 12 - Long-term Debt - Net Carrying Amount of Long-term Debt Instruments (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Credit Facility Due in November 2025 [Member]
Carrying amount of long-term debt	$ 38,480	$ 39,420
Term Loan Due in July 2033 [Member]
Carrying amount of long-term debt	10,154	10,212
Term Loan Due in July 2033 Two [Member]
Carrying amount of long-term debt	12,406	12,422
Term Loan Due in August 2026 [Member]
Carrying amount of long-term debt	245	263
Mortgage Payable Due in August 2026 [Member]
Carrying amount of long-term debt	2,111	2,089
Term Loan Due in April 2025 [Member]
Carrying amount of long-term debt	320	417
Term Loan Due in August 2028 [Member]
Carrying amount of long-term debt	3,030	3,151
Mortgage Payable Due in October 2030 [Member]
Carrying amount of long-term debt	19,969	20,066
Term Loan Due in June 2028 [Member]
Carrying amount of long-term debt	85,500	86,626
Long-term Debt, Excluding Convertible Debentures [Member]
Carrying amount of long-term debt	172,215	174,666
Unamortized financing fees	(875)	(808)
Net carrying amount	171,340	173,858
Less principal portion included in current liabilities	(16,072)	(15,506)
Total noncurrent portion of long-term debt	$ 155,268	$ 158,352

Note 12 - Long-term Debt - Ne_2

Note 12 - Long-term Debt - Net Carrying Amount of Long-term Debt Instruments (Details) (Parentheticals) € in Thousands, $ in Thousands, $ in Thousands	3 Months Ended			12 Months Ended
	Aug. 31, 2024 USD ($)	Aug. 31, 2024 CAD ($)	Aug. 31, 2024 EUR (€)	May 31, 2024 USD ($)	May 31, 2024 CAD ($)	May 31, 2024 EUR (€)	Aug. 31, 2024 CAD ($)	Aug. 31, 2024 EUR (€)	May 31, 2024 CAD ($)	May 31, 2024 EUR (€)
Credit Facility Due in November 2025 [Member]
Face amount							$ 66,000		$ 66,000
Term (Year)	3 years	3 years	3 years	3 years	3 years	3 years
Amortization period (Year)	10 years	10 years	10 years	10 years	10 years	10 years
Maturity	Nov. 30, 2025	Nov. 30, 2025	Nov. 30, 2025	Nov. 30, 2025	Nov. 30, 2025	Nov. 30, 2025
Term Loan Due in July 2033 [Member]
Face amount							25,000		25,000
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Amortization period (Year)	15 years	15 years	15 years	15 years	15 years	15 years
Maturity	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033
Periodic payment		$ 181			$ 181
Term Loan Due in July 2033 [Member] | Prime Rate [Member]
Variable rate	1%	1%	1%	1%	1%	1%
Term Loan Due in July 2033 Two [Member]
Face amount							25,000		25,000
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Amortization period (Year)	15 years	15 years	15 years	15 years	15 years	15 years
Maturity	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033	Jul. 31, 2033
Variable rate	1%	1%	1%	1%	1%	1%
Periodic payment		$ 196			$ 196
Term Loan Due in August 2026 [Member]
Face amount							1,250		1,250
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Amortization period (Year)	10 years	10 years	10 years	10 years	10 years	10 years
Maturity	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026
Periodic payment		$ 12			$ 12
Term Loan Due in August 2026 [Member] | Prime Rate [Member]
Variable rate	1.50%	1.50%	1.50%	1.50%	1.50%	1.50%
Mortgage Payable Due in August 2026 [Member]
Face amount							$ 3,750		$ 3,750
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Amortization period (Year)	20 years	20 years	20 years	20 years	20 years	20 years
Maturity	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026	Aug. 31, 2026
Periodic payment		$ 23			$ 23
Mortgage Payable Due in August 2026 [Member] | Prime Rate [Member]
Variable rate	1.50%	1.50%	1.50%	1.50%	1.50%	1.50%
Term Loan Due in April 2025 [Member]
Face amount | €								€ 1,500		€ 1,500
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Maturity	Apr. 30, 2025	Apr. 30, 2025	Apr. 30, 2025	Apr. 30, 2025	Apr. 30, 2025	Apr. 30, 2025
Periodic payment | €			€ 94			€ 94
Rate	2%			2%			2%	2%	2%	2%
Term Loan Due in August 2028 [Member]
Face amount | €								€ 3,500		€ 3,500
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Maturity	Aug. 31, 2028	Aug. 31, 2028	Aug. 31, 2028	Aug. 31, 2028	Aug. 31, 2028	Aug. 31, 2028
Periodic payment | €			€ 52			€ 52
Rate	4.59%			4.59%			4.59%	4.59%	4.59%	4.59%
Mortgage Payable Due in October 2030 [Member]
Face amount	$ 22,635			$ 22,635
Term (Year)	10 years	10 years	10 years	10 years	10 years	10 years
Maturity	Oct. 31, 2030	Oct. 31, 2030	Oct. 31, 2030	Oct. 31, 2030	Oct. 31, 2030	Oct. 31, 2030
Periodic payment	$ 57			$ 57
Mortgage Payable Due in October 2030 [Member] | Euro Interbank Offered Rate [Member]
Variable rate	1.50%	1.50%	1.50%	1.50%	1.50%	1.50%
Term Loan Due in June 2028 [Member]
Face amount	$ 90,000			$ 90,000
Term (Year)	5 years	5 years	5 years	5 years	5 years	5 years
Maturity	Jun. 30, 2028	Jun. 30, 2028	Jun. 30, 2028	Jun. 30, 2028	Jun. 30, 2028	Jun. 30, 2028
Term Loan Due in June 2028 [Member] | Minimum [Member]
Periodic payment	$ 875			$ 875
Term Loan Due in June 2028 [Member] | Maximum [Member]
Periodic payment	$ 1,750			$ 1,750

Note 13 - Convertible Debentu_3

Note 13 - Convertible Debentures Payable (Details Textual) $ / shares in Units, $ in Thousands		3 Months Ended
	May 30, 2023 USD ($) $ / shares shares	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)	May 31, 2024 USD ($)	Apr. 01, 2019 USD ($)
Repayments of Convertible Debt		$ 330	$ 0
Accretion Expense		3,067	5,544
TLRY 27 [Member]
Debt Instrument, Face Amount	$ 172,500	$ 172,500		$ 172,500
Debt Instrument, Interest Rate, Stated Percentage	5.20%	5.20%		5.20%
Debt Instrument, Convertible, Conversion Ratio	376.6478
Debt Instrument, Convertible, Multiples of Principal Amount	$ 1,000
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares	$ 2.66
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	130%
Own-share Lending Arrangement, Shares, Issued (in shares) | shares	38,500,000
Repayments of Convertible Debt	$ 7,500
Interest Expense, Debt		$ 2,243	2,243
Accretion Expense		$ 3,067	$ 2,795
APHA 24 [Member]
Debt Instrument, Face Amount				$ 350,000	$ 350,000
Debt Instrument, Interest Rate, Stated Percentage		5.25%		5.25%	5.25%

Note 13 - Convertible Debentu_4

Note 13 - Convertible Debentures Payable - Net Carrying Amount of Convertible Debentures (Details) - USD ($) $ in Thousands	12 Months Ended
	May 31, 2024	Aug. 31, 2024	May 30, 2023	Apr. 01, 2019
Deduct - current portion	$ 330	$ 0
Total convertible debentures payable, non current portion	129,583	132,650
TLRY 27 [Member]
Carrying amount of long-term debt	129,583	132,650
Face amount	172,500	172,500	$ 172,500
Unamortized discount	(42,917)	(39,850)
Convertible debentures	129,583	132,650
Contractual debenture	172,500	172,500	$ 172,500
APHA 24 [Member]
Carrying amount of long-term debt	330	0
Face amount	350,000			$ 350,000
Convertible debentures	330
Contractual debenture	350,000			$ 350,000
Debt settlement	(349,670)
Fair value adjustment	0
Convertible Debentures [Member]
Carrying amount of long-term debt	$ 129,913	$ 132,650

Note 13 - Convertible Debentu_5

Note 13 - Convertible Debentures Payable - Net Carrying Amount of Convertible Debentures (Details) (Parentheticals)	Aug. 31, 2024	May 31, 2024	May 30, 2023	Apr. 01, 2019
TLRY 27 [Member]
Rate	5.20%	5.20%	5.20%
APHA 24 [Member]
Rate	5.25%	5.25%		5.25%

Note 14 - Warrant Liability (De

Note 14 - Warrant Liability (Details Textual) - $ / shares	Aug. 31, 2024	May 31, 2024
Class of Warrant or Right, Outstanding (in shares)	6,209,000	6,209,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 5.95	$ 5.95
Percentage of Daily Cash Penalty	1%
Fair Value, Inputs, Level 3 [Member]
Estimated Fair Value of Warrant Liability Per Warrant (in dollars per share)	$ 0.412
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	3.23
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	0.50
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input	1.05
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Conversion Price [Member]
Warrants and Rights Outstanding, Measurement Input	1.61
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Share Price [Member]
Warrants and Rights Outstanding, Measurement Input	1.71
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 1.61
Warrants to Purchase Common Stock [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)	1	1

Note 15 - Stockholders' Equit_2

Note 15 - Stockholders' Equity (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	May 31, 2024
Common Stock, Shares Authorized (in shares)	1,198,000,000		1,198,000,000
Preferred Stock, Shares Authorized (in shares)	10,000,000		10,000,000
Common Stock, Shares, Issued (in shares)	875,444,828		875,444,828
Preferred Stock, Shares Issued (in shares)	0		0
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)	6,826,148
Time-based Restricted Stock Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	13,054,906	11,559,549
Performance-based Restricted Stock Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	0	7,566,146
At-the-Market Program [Member]
Stock Issued During Period, Shares, Equity Financing (in shares)	36,693,307
Stock Issued During Period, Value, Equity Financing	$ 68,279
Payments of Stock Issuance Costs	1,807
Net Proceeds from Issuance of Common Stock	$ 66,472

Note 15 - Stockholders' Equit_3

Note 15 - Stockholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Stock-based compensation expense	$ 6,917	$ 8,257
Restricted Stock Units (RSUs) [Member]
Stock-based compensation expense	$ 6,917	$ 8,257

Note 16 - Accumulated Other C_3

Note 16 - Accumulated Other Comprehensive Income (Loss) - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Balance	$ 3,443,178	$ 3,329,943
Other comprehensive loss	4,160	3,209
Balance	3,483,414	3,401,556
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance	(43,499)	(46,610)
Other comprehensive loss	3,622	3,049
Balance	(39,877)	(43,561)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]
Balance	(43,499)	(46,610)
Other comprehensive loss	3,622	3,049
Balance	$ (39,877)	$ (43,561)

Note 17 - Non-controlling Int_3

Note 17 - Non-controlling Interests (Details Textual)	Aug. 31, 2024	Aug. 31, 2021
Superhero Acquisition LP [Member]
Noncontrolling Interest, Ownership Percentage by Parent	68%	68%
CC Pharma Nordic ApS [Member]
Noncontrolling Interest, Ownership Percentage by Parent	75%
Aphria Diamond [Member]
Noncontrolling Interest, Ownership Percentage by Parent	51%
ColCanna S.A.S. [Member]
Noncontrolling Interest, Ownership Percentage by Parent	90%

Note 17 - Non-controlling Int_4

Note 17 - Non-controlling Interests - Summary of Balance Sheet Information (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Current assets	$ 725,883	$ 677,710
Current liabilities	(293,549)	(299,170)
Superhero Acquisition LP [Member]
Current assets	0	0
Non-current assets	32,000	32,000
Current liabilities	0	0
Non-current liabilities	0	0
Net assets	32,000	32,000
CC Pharma Nordic ApS [Member]
Current assets	14	12
Non-current assets	0	0
Current liabilities	(17)	(9)
Non-current liabilities	0	0
Net assets	(3)	3
Aphria Diamond [Member]
Current assets	108,030	95,720
Non-current assets	123,694	124,675
Current liabilities	(133,014)	(130,945)
Non-current liabilities	(23,359)	(24,482)
Net assets	75,351	64,968
ColCanna S.A.S. [Member]
Current assets	11	3
Non-current assets	3,355	3,637
Current liabilities	(6,993)	(6,913)
Non-current liabilities	(1,451)	(1,452)
Net assets	(5,078)	(4,725)
Subsidiaries [Member]
Current assets	108,055	95,735
Non-current assets	159,049	160,312
Current liabilities	(140,024)	(137,867)
Non-current liabilities	(24,810)	(25,934)
Net assets	$ 102,270	$ 92,246

Note 17 - Non-controlling Int_5

Note 17 - Non-controlling Interests - Summary of Income Statement Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Net (loss) income	$ (34,652)	$ (55,863)
Other comprehensive (loss) income	4,160	3,209
Net comprehensive (loss) income	(30,492)	(52,654)
Comprehensive (loss) income attributable to NCI	5,051	15,822
Subsidiaries [Member]
Revenue	18,558	39,230
Total expenses	9,851	15,887
Net (loss) income	8,707	23,343
Other comprehensive (loss) income	1,317	168
Net comprehensive (loss) income	10,024	23,511
Comprehensive (loss) income attributable to NCI	5,051	11,752
Net comprehensive (loss) income attributable to NCI	5,051	15,822
Additional income attributable to NCI		4,070
Superhero Acquisition LP [Member]
Revenue	0	0
Total expenses	0	0
Net (loss) income	0	0
Other comprehensive (loss) income	0	0
Net comprehensive (loss) income	$ 0	$ 0
Non-controlling interest %	32%	32%
Comprehensive (loss) income attributable to NCI	$ 0	$ 0
Net comprehensive (loss) income attributable to NCI	0	0
Additional income attributable to NCI		0
CC Pharma Nordic ApS [Member]
Revenue	0	0
Total expenses	5	35
Net (loss) income	(5)	(35)
Other comprehensive (loss) income	(1)	(20)
Net comprehensive (loss) income	$ (6)	$ (55)
Non-controlling interest %	25%	25%
Comprehensive (loss) income attributable to NCI	$ (2)	$ (14)
Net comprehensive (loss) income attributable to NCI	(2)	(14)
Additional income attributable to NCI		0
Aphria Diamond [Member]
Revenue	18,558	39,230
Total expenses	9,216	15,636
Net (loss) income	9,342	23,594
Other comprehensive (loss) income	1,041	533
Net comprehensive (loss) income	$ 10,383	$ 24,127
Non-controlling interest %	49%	49%
Comprehensive (loss) income attributable to NCI	$ 5,088	$ 11,822
Net comprehensive (loss) income attributable to NCI	5,088	15,892
Additional income attributable to NCI		4,070
ColCanna S.A.S. [Member]
Revenue	0	0
Total expenses	630	216
Net (loss) income	(630)	(216)
Other comprehensive (loss) income	277	(345)
Net comprehensive (loss) income	$ (353)	$ (561)
Non-controlling interest %	10%	10%
Comprehensive (loss) income attributable to NCI	$ (35)	$ (56)
Net comprehensive (loss) income attributable to NCI	$ (35)	(56)
Additional income attributable to NCI		$ 0

Note 18 - Income Taxes (Details

Note 18 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Income Tax Expense (Benefit)	$ 886	$ 7,264

Note 19 - Commitments and Con_3

Note 19 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	Mar. 17, 2023	Aug. 31, 2024	May 31, 2024
Loss Contingency Accrual		$ 24,413	$ 24,378
Settled Litigation [Member] | K. Dickson v. Tilray, Inc. [Member]
Loss Contingency, Damages Awarded, Value	$ 3,734

Note 19 - Commitments and Con_4

Note 19 - Commitments and Contingencies - Schedule of Commitments (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Total	$ 412,288
Total, 2024	56,118
Total, 2025	70,090
Total, 2026	185,104
Total, 2027	66,762
Total, thereafter	34,214
Material Purchase Obligations [Member]
Purchase obligations, total	67,142
Purchase obligations, 2024	39,615
Purchase obligations, 2025	27,527
Purchase obligations, 2026	0
Purchase obligations, 2027	0
Purchase obligations, thereafter
Capital Addition Purchase Commitments [Member]
Purchase obligations, total	431
Purchase obligations, 2024	431
Purchase obligations, 2025	0
Purchase obligations, 2026	0
Purchase obligations, 2027	0
Purchase obligations, thereafter	0
Long-term Debt, Excluding Convertible Debentures [Member]
Debt instrument	172,215	$ 174,666
Debt Instrument, 2024	16,072
Long-term debt repayment	42,563
Debt instrument, 2026	12,604
Debt instrument, 2027	66,762
Debt instrument, thereafter	34,214
Convertible Debentures [Member]
Debt instrument	172,500
Debt Instrument, 2024	0
Long-term debt repayment	0
Debt instrument, 2026	172,500
Debt instrument, 2027	0
Debt instrument, thereafter	$ 0

Note 20 - Net Revenue - Compone

Note 20 - Net Revenue - Components of Net Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Net revenue	$ 200,044	$ 176,949
Beverage Alcohol Business [Member]
Revenue	59,163	25,339
Excise taxes	(3,191)	(1,177)
Net revenue	55,972	24,162
Cannabis Segment [Member]
Revenue	81,194	96,884
Excise taxes	(19,945)	(26,551)
Net revenue	61,249	70,333
Tilray Pharma Segment [Member]
Net revenue	68,071	69,157
Wellness Business [Member]
Net revenue	$ 14,752	$ 13,297

Note 21 - Cost of Goods Sold -

Note 21 - Cost of Goods Sold - Components of Cost of Goods Sold (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Cost of goods sold	$ 140,338	$ 132,753
Beverage Alcohol Business [Member]
Cost of goods sold	33,050	11,266
Cannabis Segment [Member]
Cost of goods sold	37,054	50,517
Distribution Business [Member]
Cost of goods sold	60,138	61,468
Wellness Business [Member]
Cost of goods sold	$ 10,096	$ 9,502

Note 22 - General and Adminis_3

Note 22 - General and Administrative Expenses - Components of General and Administrative Expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Salaries and wages	$ 21,567	$ 16,775
Office and general	9,260	8,168
Stock-based compensation	6,917	8,257
Insurance	2,455	3,849
Professional fees	1,178	1,499
(Gain) loss on sale of capital assets	(26)	3
Travel and accommodation	1,493	1,107
Rent	1,269	858
Total	$ 44,113	$ 40,516

Note 23 - Restructuring Charg_2

Note 23 - Restructuring Charges (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Restructuring Costs	$ 4,247	$ 915
Distribution Business [Member]
Restructuring Costs	121
Superhero L P [Member]
Restructuring and Related Cost, Incurred Cost	1,084
Employee Severance [Member] | Beverage Alcohol Business [Member]
Restructuring Costs	123
Employee Severance [Member] | HEXO Acquisition [Member]
Restructuring Costs	2,582
Facility Closing [Member] | Fort Collins Facility [Member]
Restructuring Costs	82
Facility Closing [Member] | Truss Beverage Company [Member]
Restructuring Costs	$ 255

Note 24 - Non-operating Incom_3

Note 24 - Non-operating Income (Expense), Net - Components of Non-operating Income (Expense) (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Change in fair value of convertible debenture payable	$ 0	$ (2,147)
Change in fair value of warrant liability	696	(8,198)
Foreign exchange gain (loss)	11,881	6,267
Loss on long-term investments	(39)	(109)
Other non-operating (losses) gains, net	108	(215)
Total	$ 12,646	$ (4,402)

Note 25 - Fair Value Measurem_3

Note 25 - Fair Value Measurements (Details Textual) $ in Thousands	3 Months Ended
	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)	May 31, 2024 USD ($)
Contingent Consideration [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs	$ (15,000)		$ (15,000)
SweetWater, Montauk, and Truss [Member] | Contingent Consideration [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)	$ 0	$ (11,107)
Maximum [Member] | SweetWater, Montauk, and Truss [Member] | Measurement Input, Probability of Achievement [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	100
Minimum [Member] | SweetWater, Montauk, and Truss [Member] | Measurement Input, Probability of Achievement [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	0
Long-term Debt, Excluding Convertible Debentures [Member]
Long-Term Debt, Percentage Bearing Fixed Interest, Amount	$ 3,350		3,568
Convertible Debt [Member]
Convertible Debt	$ 172,500		$ 172,830

Note 25 - Fair Value Measurem_4

Note 25 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Equity investments measured at fair value	$ 2,353	$ 2,359
Contingent consideration	(15,000)	(15,000)
Fair Value, Recurring [Member]
Cash and cash equivalents	205,186	228,340
Marketable securities	74,869	32,182
Convertible notes receivable	32,000	32,000
Equity investments measured at fair value	7,853	7,859
Warrant liability	(2,557)	(3,253)
Contingent consideration	(15,000)	(15,000)
Total recurring fair value measurements	302,351	281,798
Fair Value, Recurring [Member] | APHA 24 [Member]
APHA 24 Convertible debenture	0	(330)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents	205,186	228,340
Marketable securities	74,869	32,182
Convertible notes receivable	0	0
Equity investments measured at fair value	891	919
Warrant liability	0	0
Contingent consideration	0	0
Total recurring fair value measurements	280,946	261,441
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | APHA 24 [Member]
APHA 24 Convertible debenture	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents	0	0
Marketable securities	0	0
Convertible notes receivable	0	0
Equity investments measured at fair value	1,462	1,440
Warrant liability	0	0
Contingent consideration	0	0
Total recurring fair value measurements	1,462	1,440
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | APHA 24 [Member]
APHA 24 Convertible debenture	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents	0	0
Marketable securities	0	0
Convertible notes receivable	32,000	32,000
Equity investments measured at fair value	5,500	5,500
Warrant liability	(2,557)	(3,253)
Contingent consideration	(15,000)	(15,000)
Total recurring fair value measurements	19,943	18,917
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | APHA 24 [Member]
APHA 24 Convertible debenture	$ 0	$ (330)

Note 25 - Fair Value Measurem_5

Note 25 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis - Reconciliation of Level 3 Assets and Liabilities (Details) - Fair Value, Inputs, Level 3 [Member] $ in Thousands	3 Months Ended
	Aug. 31, 2024 USD ($)
Equity Investments [Member]
Balance	$ 5,500
Additions/(Repayments)	0
Redemption	0
Unrealized gain (loss) on fair value	0
Impairments	0
Balance	5,500
Warrant Liability [Member]
Balance	(3,253)
Additions/(Repayments)	0
Redemption	0
Unrealized gain (loss) on fair value	696
Impairments	0
Balance	(2,557)
Contingent Consideration [Member]
Balance	(15,000)
Additions/(Repayments)	0
Redemption	0
Unrealized gain (loss) on fair value	0
Impairments	0
Balance	(15,000)
Long-Term Debt [Member] | APHA 24 [Member]
Balance	(330)
Additions/(Repayments)	330
Redemption	0
Unrealized gain (loss) on fair value	0
Impairments	0
Balance	0
Notes Receivable [Member]
Balance	32,000
Additions/(Repayments)	0
Redemption	0
Unrealized gain (loss) on fair value	0
Impairments	0
Balance	$ 32,000

Note 25 - Fair Value Measurem_6

Note 25 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis - Inputs Used to Recognize Unrealized Gain (Loss) on Fair Value (Details) - Minimum [Member]	Aug. 31, 2024
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Expected Term [Member]
Debt instrument, measurement input
Warrant liability	1
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member]
Warrant liability	0.50
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Conversion Rate [Member]
Contingent consideration	1
Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rate [Member]
Contingent consideration	0.11

Note 26 - Segment Reporting (De

Note 26 - Segment Reporting (Details Textual) $ in Thousands	3 Months Ended
	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)
Number of Reportable Segments	4
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Major Customers [Member]
Number Of Major Customers	0	0
Advisory Services Agreement With HEXO [Member] | Advisory Services Revenue [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 0	$ 1,500

Note 26 - Segment Reporting - S

Note 26 - Segment Reporting - Schedule of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Net revenue	$ 200,044	$ 176,949
Cost of goods sold	140,338	132,753
Gross Profit	59,706	44,196
Cannabis Segment [Member]
Net revenue	61,249	70,333
Cost of goods sold	37,054	50,517
Gross Profit	24,195	19,816
Revenue	81,194	96,884
Excise taxes	(19,945)	(26,551)
Cannabis Segment [Member] | Medical Cannabis Products [Member]
Revenue	6,261	6,142
Cannabis Segment [Member] | Adult-use Cannabis Products [Member]
Revenue	57,235	71,195
Cannabis Segment [Member] | Wholesale Cannabis Products [Member]
Revenue	5,507	5,295
Cannabis Segment [Member] | International Cannabis Products [Member]
Revenue	12,191	14,252
Beverage Alcohol Business [Member]
Net revenue	55,972	24,162
Cost of goods sold	33,050	11,266
Gross Profit	22,922	12,896
Revenue	59,163	25,339
Excise taxes	(3,191)	(1,177)
Tilray Pharma Segment [Member]
Net revenue	68,071	69,157
Cost of goods sold	60,138	61,468
Gross Profit	7,933	7,689
Wellness Business [Member]
Net revenue	14,752	13,297
Cost of goods sold	10,096	9,502
Gross Profit	$ 4,656	$ 3,795

Note 26 - Segment Reporting - G

Note 26 - Segment Reporting - Geographic Net Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Net revenue	$ 200,044	$ 176,949
UNITED STATES
Net revenue	63,880	31,489
CANADA
Net revenue	55,905	62,032
EMEA [Member]
Net revenue	77,672	79,704
Rest of World [Member]
Net revenue	$ 2,587	$ 3,724

Note 26 - Segment Reporting -_2

Note 26 - Segment Reporting - Geographic Capital Assets (Details) - USD ($) $ in Thousands	Aug. 31, 2024	May 31, 2024
Capital assets	$ 555,136	$ 558,247
UNITED STATES
Capital assets	140,900	141,314
CANADA
Capital assets	312,432	313,359
EMEA [Member]
Capital assets	98,433	99,921
Rest of World [Member]
Capital assets	$ 3,371	$ 3,653

Note 27 - Subsequent Events (De

Note 27 - Subsequent Events (Details Textual) - USD ($) $ / shares in Units, $ in Thousands							3 Months Ended
	Sep. 17, 2024	Sep. 13, 2024	Sep. 12, 2024	Sep. 10, 2024	Sep. 01, 2024	May 30, 2023	Aug. 31, 2024	Aug. 31, 2023	May 31, 2024
Proceeds from Issuance of Common Stock							$ 66,472	$ 0
Repayments of Convertible Debt							$ 330	$ 0
Common Stock, Par or Stated Value Per Share (in dollars per share)							$ 0.0001		$ 0.0001
TLRY 27 [Member]
Repayments of Convertible Debt						$ 7,500
At-the-Market Program [Member]
Stock Issued During Period, Shares, Equity Financing (in shares)							36,693,307
Payments of Stock Issuance Costs							$ 1,807
Net Proceeds from Issuance of Common Stock							$ 66,472
Subsequent Event [Member] | Double Diamond Holdings Ltd. [Member]
Asset Acquisition, Acquired Payables	$ 23,792
Stock Issued During Period, Shares, Settlement of Financing Liability (in shares)	13,217,588
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Subsequent Event [Member] | TLRY 27 [Member]
Repayments of Convertible Debt		$ 165,000	$ 7,500
Stock Issued During Period, Shares, For The Repayment of Convertible Debt (in shares)			4,484,240
Interest Paid, Excluding Capitalized Interest, Operating Activities			$ 102
Subsequent Event [Member] | At-the-Market Program [Member]
Stock Issued During Period, Shares, Equity Financing (in shares)				10,132,247
Proceeds from Issuance of Common Stock				$ 17,059
Payments of Stock Issuance Costs				341
Net Proceeds from Issuance of Common Stock				$ 16,718
Atwater Brewery, Hop Valley Brewing Company, Terrapin Beer Co., and Revolver Brewing [Member] | Subsequent Event [Member]
Business Combination, Consideration Transferred					$ 23,079